NCT00540826View on ClinicalTrials.gov

Treatment Compliance in Children and Adolescents on ADHD Medication

CompletedOBSERVATIONAL

Enrollment

518

Participants

Timeline

Start Date

November 30, 2007

Study Completion Date

June 30, 2009

Conditions

ADHD

Interventions

DRUG

Atomoxetine

in-label use

DRUG

stimulants (any approved ADHD medication)

in-label use

Trial Locations (1)

D-61350

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bad Homburg

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00540826 - Treatment Compliance in Children and Adolescents on ADHD Medication | Biotech Hunter | Biotech Hunter